Workflow
Eli Lilly Nails Oral GLP-1 Trial—Here's What It Means for LLY
GLPGlobal Partners LP(GLP) MarketBeat·2025-04-23 11:33

Eli Lilly and Company TodayLLYEli Lilly and Company827.87+9.85 (+1.20827.87 +9.85 (+1.20%) 52-Week Range677.09▼972.53DividendYield0.72972.53Dividend Yield0.72%P/E Ratio70.70Price Target1,017.00Add to WatchlistThe world’s largest pharmaceutical stock, Eli Lilly and Company NYSE: LLY, is back in the green in 2025 as of the Apr. 21 close. Shares were down moderately in 2025 through mid-April. However, huge news came out regarding one of the company’s experimental drugs, causing shares to spike by over 14%. That drug is orforglipron, Eli Lilly’s ...